Dinutuximab Combination Therapy Becomes First Approval for High-Risk Neuroblastoma
Journal of Community and Supportive Oncology - United States
doi 10.12788/jcso.0172
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2015
Authors
Publisher
Frontline Medical Communications, Inc.